Meta-analysis of rare and adverse event data-Reference-Cited by-同舟云学术

Meta-analysis of rare and adverse event data

Published:2002-08 Issue:4 Volume:2 Page:367-379
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Sutton Alexander J,Cooper Nicola J,Lambert Paul C,Jones David R,Abrams Keith R,Sweeting Michael J

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737167.2.4.367

Reference56 articles.

1. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song E Methods for meta-analysis in medical research. John Wiley, London, UK (2000).

2. The Many Modes of Meta

3. Li wan Po A, Herxheimer A, Poolsup N, Aziz Z. How do Cochrane reviewers address adverse effects of drug therapy? (abstract) 8th Annual Cochrane Colloquium. October 25-29, Cape Town, South Africa (2000).

4. Completeness of Safety Reporting in Randomized Trials

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Rare Events in Outcomes Research Using Department of Defense Data: Intravenous Immune Globulin Therapy for Bullous Pemphigoid;2024-02-01

2. Meta-analysis of Censored Adverse Events;The New England Journal of Statistics in Data Science;2024

3. Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis;Leukemia Research;2023-08

4. Measuring the impact of zero-cases studies in evidence synthesis practice using the harms index and benefits index (Hi-Bi);BMC Medical Research Methodology;2023-03-13

5. Reporting Quality of Oral TCM Systematic Reviews Based on the PRISMA Harms Checklist from 2013 to 2020;Evidence-Based Complementary and Alternative Medicine;2023-01-24